Gaurav Shah - 16 Aug 2024 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
CEO, Director
Signature
/s/ Martin Wilson, as attorney-in-fact for Gaurav Shah
Issuer symbol
RCKT
Transactions as of
16 Aug 2024
Net transactions value
-$178,564
Form type
4
Filing time
20 Aug 2024, 16:26:39 UTC
Previous filing
20 May 2024
Next filing
25 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCKT Common Stock Sale $178,564 -9,650 -1.3% $18.50 718,419 16 Aug 2024 Direct F1
holding RCKT Common Stock 207,897 16 Aug 2024 By Spouse
holding RCKT Common Stock 198,341 16 Aug 2024 By Gaurav D. Shah Irrevocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.